BACKGROUND Tackling problematic polypharmacy requires tailoring the use of medicines
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Older people with chronic disease have great potential to benefit from their medications but
are also at high risk of harm from their medications. The use of medications is particularly …

Minimising the harm from inappropriate prescribing in older populations is a major urgent
concern for modern healthcare systems. In everyday encounters between prescribers and …

Avoiding inappropriate polypharmacy has become increasingly recognised as a safety
imperative for older patient care. Deprescribing is an active process of reviewing all …

Introduction The majority of older people with chronic diseases are prescribed multiple
medicines resulting in polypharmacy. The extrapolation of the 'single disease …

Older people are prescribed a disproportionate number of medications. Polypharmacy leads
to reduced compliance, increases the risk of adverse drug effects and may lead to poor …

Older adults commonly end up on many medications. Deprescribing is an important part of
individualizing care for older adults. It is an opportunity to discuss treatment options and …

Older patients often have multimorbidity, frequently resulting in polypharmacy.
Independently, multimorbidity and polypharmacy are among the biggest risk factors for …

Background Mixed findings about deprescribing impact have emerged from varied study
designs, interventions, outcome measures and targeting sub-categories of medications or …

The use of multiple medicines, known as polypharmacy, poses a risk of harm that is greatest
in older adults with multimorbidity. Deprescribing aims to improve health outcomes through …